+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radiopharmaceutical"

Radiopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Radiopharmaceuticals - Global Strategic Business Report

  • Report
  • April 2024
  • 739 Pages
  • Global
From
Radiopharmaceuticals Global Market Report 2024 - Product Thumbnail Image

Radiopharmaceuticals Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
Global Radiopharmaceuticals Market 2023-2027 - Product Thumbnail Image

Global Radiopharmaceuticals Market 2023-2027

  • Report
  • August 2023
  • 160 Pages
  • Global
From
From
From
Loading Indicator

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect. The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals. Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more